HIV.gov

See our list of federal resources on COVID-19 and people with HIV.

View CDC’s FAQs: What to know about HIV and COVID-19.

Additional information is available at CDC.gov/coronavirus and USA.gov/coronavirus.

The Ready, Set, PrEP program provides pre-exposure prophylaxis (PrEP) medications at no cost to individuals who qualify. To check eligibility and enroll in the program click here.

Patients enrolled in the Ready, Set, PrEP program fill their prescription for PrEP medication at no cost at their choice of participating pharmacies or through mail.

Learn about Ending the HIV Epidemic: A Plan for America. Subscribe to receive emails with program updates. Click here for information on the Ready, Set, PrEP programs, which provides PrEP medications at no cost to individuals who qualify, and to check eligibility and enroll in the program.

AHEAD, an online data visualization tool, is a critical component of Ending the HIV Epidemic: A Plan for America, a national initiative to reduce the number of new HIV diagnoses in the United States. To explore the AHEAD dashboard and our progress on ending the HIV epidemic in America, click here.

Stay informed about the Ending the HIV Epidemic: A Plan for America by signing up for periodic email updates.

On September 14^th, clinicalinfo.HIV.gov launched. The HIV treatment (clinical) guidelines, drug database, and glossary that were part of AIDSinfo and infoSIDA have moved to HIV.gov.